Works matching IS 02698811 AND DT 2015 AND VI 29 AND IP 2

Results: 14

Dementia praecox redux: A systematic review of the nicotinic receptor as a target for cognitive symptoms of schizophrenia.

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 2, p. 197, doi. 10.1177/0269881114564096

By:

Rowe, Arann R;
Mercer, Louise;
Casetti, Valentina;
Sendt, Kyra-Verena;
Giaroli, Giovanni;
Shergill, Sukhwinder S;
Tracy, Derek K

Publication type:

Article

Functional brain connectivity phenotypes for schizophrenia drug discovery.

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 2, p. 169, doi. 10.1177/0269881114563635

By:

Dawson, Neil;
Morris, Brian J;
Pratt, Judith A

Publication type:

Article

Recent genetic findings in schizophrenia and their therapeutic relevance.

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 2, p. 85, doi. 10.1177/0269881114553647

By:

Harrison, Paul J

Publication type:

Article

Schizophrenia drug discovery and development in an evolving era: Are new drug targets fulfilling expectations?

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 2, p. 230, doi. 10.1177/0269881114565806

By:

Dunlop, John;
Brandon, Nicholas J

Publication type:

Article

The thalamic reticular nucleus: A functional hub for thalamocortical network dysfunction in schizophrenia and a target for drug discovery.

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 2, p. 127, doi. 10.1177/0269881114565805

By:

Pratt, Judith A;
Morris, Brian J

Publication type:

Article

Schizophrenia in the 21st century: New insights and translation into improved therapies.

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 2, p. 83, doi. 10.1177/0269881114566743

By:

Pratt, Judith

Publication type:

Article

Schizophrenia biomarkers: Translating the descriptive into the diagnostic.

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 2, p. 138, doi. 10.1177/0269881114566631

By:

Pickard, Benjamin S

Publication type:

Article

Glutamate and dopamine in schizophrenia: An update for the 21st century.

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 2, p. 97, doi. 10.1177/0269881114563634

By:

Howes, Oliver;
McCutcheon, Rob;
Stone, James

Publication type:

Article

Dissecting negative symptoms in schizophrenia: Opportunities for translation into new treatments.

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 2, p. 116, doi. 10.1177/0269881114562092

By:

Foussias, George;
Siddiqui, Ishraq;
Fervaha, Gagan;
Agid, Ofer;
Remington, Gary

Publication type:

Article

Facial affect processing deficits in schizophrenia: A meta-analysis of antipsychotic treatment effects.

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 2, p. 224, doi. 10.1177/0269881114560184

By:

Gabay, Anthony S;
Kempton, Matthew J;
Mehta, Mitul A

Publication type:

Article

Developing treatments for cognitive deficits in schizophrenia: The challenge of translation.

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 2, p. 178, doi. 10.1177/0269881114555252

By:

Young, JW;
Geyer, MA

Publication type:

Article

Structural magnetic resonance imaging markers of susceptibility and transition to schizophrenia: A review of familial and clinical high risk population studies.

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 2, p. 144, doi. 10.1177/0269881114541015

By:

Bois, C;
Whalley, HC;
McIntosh, AM;
Lawrie, SM

Publication type:

Article

Neural oscillations as a translational tool in schizophrenia research: Rationale, paradigms and challenges.

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 2, p. 155, doi. 10.1177/0269881114562093

By:

Phillips, Keith G;
Uhlhaas, Peter J

Publication type:

Article

Re-examining the role of benzodiazepines in the treatment of schizophrenia: A systematic review.

Published in:

Journal of Psychopharmacology, 2015, v. 29, n. 2, p. 212, doi. 10.1177/0269881114541013

By:

Sim, Faye;
Sweetman, Isabel;
Kapur, Shitij;
Patel, Maxine X

Publication type:

Article